Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Recipharm

Explore full profile

Recipharm is a contract development and manufacturing organisation (CDMO)

Stockholm, SwedenFounded 1995Biotech & Life Sciences
Valuation $3.76B Market cap · 2026
Revenue $910M Latest reported FY
EBITDA $265M Latest reported FY

At a glance

Status
Listed
Founded
1995
Headquarters
Stockholm, Sweden
Listing
IPO 2014
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Talent

Book a demo to see the people
Employees mapped 3,134 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 29 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
18 countries with
team presence
🇮🇳 India20.7%
🇮🇹 Italy14%
🇫🇷 France12.4%
🇸🇪 Sweden11.7%
🇵🇹 Portugal10.8%
Top 5 of 18 shown
Web traffic by country
24K monthly visits
across markets
🇺🇸 United States16.3%
🇸🇪 Sweden15.4%
🇵🇹 Portugal12.5%
🇬🇧 United Kingdom11.7%
🇩🇪 Germany10%
Top 5 markets shown

Patents

Estimated portfolio value
$84M

45 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Recipharm was the backer or acquirer, 2014–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

10 deals across Recipharm's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Recipharm's portfolio, mapped.

        Stage
        Period
        10 of 10 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Recipharm on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Recipharm on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles